Designing a Benefit-Risk Assessment of Maintenance Therapy with an Oral Versus a Long-Acting Injectable Agent in Schizophrenia
暂无分享,去创建一个
L. Dixon | J. Gold | J. Hulihan | L. Alphs | Jacqueline N. Kiwanuka | Davis | L. Mao | S. Kaiser | N. Turner | S. Rodriguez | Leeka Hubzin | S. August | R. Ferziger | John